Clinical Research Directory
Browse clinical research sites, groups, and studies.
Daily Aspirin Treatment After Preeclampsia
Sponsor: Anna Stanhewicz, PhD
Summary
Women who develop preeclampsia during pregnancy are four times more likely to develop cardiovascular disease later in life, even if they are otherwise healthy. The reason why this occurs may be related to lasting blood vessel damage after the pregnancy but there are currently no specific treatment strategies to prevent this disease progression. This study addresses this public health issue by examining whether starting low dose aspirin therapy after pregnancy is an effective treatment for lasting blood vessel damage in order to inform better clinical management of cardiovascular disease risk in women who have had preeclampsia.
Official title: Aspirin for the Treatment of Vascular Dysfunction After Preeclampsia
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2023-11-01
Completion Date
2026-06
Last Updated
2025-12-15
Healthy Volunteers
No
Conditions
Interventions
Aspirin
162mg aspirin capsule
Placebo
placebo capsule
Locations (1)
University of Iowa
Iowa City, Iowa, United States